1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000301589, RPCI-DS-9701, NCT00060268
|
|
2.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000441205, I 30404, RPCI-I-30404, NCT00281736
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000563948, RPCI-I-98707, I98707, NCT00528775
|
|
4.
|
Phase: Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000068696, P30CA016056, RPCI-DS-95-34, NCI-G01-1953, NCT00017485
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000068974, RPCI-RP-0005, NCI-G01-2023, NCT00025571
|
|
6.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: I 109307, RPCI-I-109307, NCT00670397
|
|
7.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000595166, RPCI-I-119207, I 119207, NCT00675233
|
|
8.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: I 170910, NCT01140178
|